| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859253 Metalloproteinase inhibitors |
| 01/12/1999 | US5859219 Isolated nucleotide sequences used for detection of infection as primers for amplification and probes for hybridization; antiulcer agents; anticancer agents |
| 01/12/1999 | US5859061 Matrix metalloproteinase inhibitors; treating diseases involving connective tissue degradation |
| 01/12/1999 | US5859054 Leukotriene B4 derivatives, process for their production and their use as pharmaceutical agents |
| 01/12/1999 | US5859041 Substituted imidazoles having cytokine inhibitory activity |
| 01/12/1999 | US5859034 Tri-substituted phenyl compounds which have useful pharmaceutical activity |
| 01/12/1999 | US5859032 Pyridine derivative, anti-ulcer drug, and antibacterial drug |
| 01/12/1999 | US5859029 Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present |
| 01/12/1999 | US5859007 Treatment of diabetes, obesity |
| 01/12/1999 | US5859006 Tetracyclic derivatives; process of preparation and use |
| 01/12/1999 | US5859004 Use of heterocyclic compounds for the treatment of conditions caused by malfunctioning of the nicotinic cholinergic system |
| 01/12/1999 | US5858784 Aerosol transfecting agent |
| 01/12/1999 | US5858710 Tumor-associated kazal inhibitor-like polypeptides and encoding polynucleotides |
| 01/12/1999 | US5858413 Contains at least one antacid active substance, sugar or sugar alcohol and water; liquid to semisolid consistency |
| 01/12/1999 | US5858400 Co-administering an agent having large liposomes that include phospholipids substantially free of sterol |
| 01/12/1999 | US5858365 Administering butyric acid and an amino acid, heptafluorobutyric acid, 3-chloropropionic acid, beta-chloro-l-alanine hydrochloride and isobutyramide for ulcers |
| 01/12/1999 | CA2065809C Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| 01/07/1999 | WO1999000423A1 Protein that binds trail |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000380A1 Omeprazole sodium salt |
| 01/07/1999 | WO1999000368A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 01/07/1999 | WO1999000136A1 Control of acidic gut syndrome |
| 01/07/1999 | WO1999000112A1 Sucralfate-containing composition and process for the preparation thereof |
| 01/07/1999 | WO1999000106A1 Intra-oral antioxidant preparations |
| 01/07/1999 | WO1998039463A3 Lentivirus based vector and vector system |
| 01/07/1999 | EP0889135A1 Exocellular polysaccharide produced by streptococcus thermophilus |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889043A1 5,11-DIHYDRODIBENZ b,e] 1,4]OXAZEPINE DERIVATIVES AND DRUG COMPOSITIONS CONTAING THE DERIVATIVES |
| 01/07/1999 | EP0888358A1 Piperidine derivatives |
| 01/07/1999 | EP0888357A1 Azaspiro derivatives |
| 01/07/1999 | EP0888340A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 01/07/1999 | EP0888337A1 Piperidone tachykinin antagonists |
| 01/07/1999 | EP0888336A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 01/07/1999 | EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 01/07/1999 | EP0888324A1 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
| 01/07/1999 | EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/1999 | EP0888293A1 N-acylaminoalkylhydrazinecarboximidamides |
| 01/07/1999 | EP0888278A1 Antidiabetic agents |
| 01/07/1999 | EP0888124A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888118A1 Enhancement of microbial colonisation of the gastrointestinal tract |
| 01/07/1999 | EP0888115A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | EP0525076B1 Recombinant bile salt activated lipases |
| 01/07/1999 | CA2294904A1 Control of acidic gut syndrome |
| 01/07/1999 | CA2294725A1 Intra-oral antioxidant preparations |
| 01/07/1999 | CA2294704A1 Protein that binds trail |
| 01/07/1999 | CA2291734A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 01/06/1999 | CN1204332A Method for synthesis of benzimidazole compound |
| 01/06/1999 | CN1204315A New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 01/06/1999 | CN1203818A Yatengning medical cigarette and its preparing method |
| 01/06/1999 | CN1203809A Traditional Chinese medicine preparation for curing liver-gallbladder disease |
| 01/06/1999 | CN1203807A Medicine for curing recurrent stomatocace and Behcet's syndrome |
| 01/06/1999 | CN1203803A Powder for curing ulcerative colitis and proctitis ulcerosa |
| 01/06/1999 | CN1203798A Oral Chinese medicine composition for curing gastric cancer |
| 01/06/1999 | CN1203795A Pilose antler-wood frog oil oral liquor and preparing method thereof |
| 01/05/1999 | US5856574 Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/05/1999 | US5856564 Condensed benzazepine derivative and pharmaceutical composition thereof |
| 01/05/1999 | US5856354 Tachykinin antagonists |
| 01/05/1999 | US5856349 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/05/1999 | US5856344 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them |
| 01/05/1999 | US5856338 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparation comprising them |
| 01/05/1999 | US5856335 Substituted aminothienopyridines, pharmaceutical composition and use |
| 01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| 01/05/1999 | US5856316 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 01/05/1999 | CA2164286C Indole derivatives in the treatment of emesis |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 12/30/1998 | WO1998058928A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 12/30/1998 | WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 12/30/1998 | WO1998058925A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 12/30/1998 | WO1998058910A1 Prostaglandin pharmaceutical compositions |
| 12/30/1998 | EP0887416A2 Human AFC1 |
| 12/30/1998 | EP0887415A2 Human RCE1 |
| 12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
| 12/30/1998 | EP0887345A1 4'-trifluoromethylbiphenyl-2-carboxylic acid-[2-(2-acetylaminoethyl)-1,2,3,4-tetrahydroisoquinolin-6-yl]amide hydrochloride as apo B-secretion/MTP inhibitors |
| 12/30/1998 | EP0801570A4 Formulations and methods for reducing skin irritation |
| 12/30/1998 | EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 12/30/1998 | EP0592478B1 Use of lipases to produce drugs |
| 12/30/1998 | CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor |
| 12/30/1998 | CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate |
| 12/30/1998 | CN1203232A 2-carboxymethyl-5-(5-fluoro cyti midine-1-yl) 1,3-oxythiapentane and its derivatives |
| 12/30/1998 | CN1203079A Liquid antiacid compositions |
| 12/30/1998 | CA2294453A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 12/30/1998 | CA2294259A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 12/29/1998 | US5854412 Chemokine N-terminal deletion mutations |
| 12/29/1998 | US5854261 Prokinetic compounds |
| 12/29/1998 | US5854260 Enterokinetic benzamide |
| 12/29/1998 | US5854256 Quinuclidine derivatives |
| 12/29/1998 | US5854249 Opioid diarylmethylpiperazines and piperidines |
| 12/29/1998 | US5854239 Diazabicyclic neuokinin antagonists |
| 12/29/1998 | US5853699 Use of tetra azacycle complexes as x-ray diagnostic agents for the liver and gallbladder |